Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
You must log in or register to comment.
Overall, we rate The South China Morning Post Left-Center biased based on editorial positions that moderately favor the left and Mixed for factual reporting due to poor sourcing.
Does it actually work or are the chinese lying like always? Paying off the regulator to get their trash passed I bet.
Probably false news. SCMP is a biased magazine and these figures cannot be found in any official sources.
